New nanoparticle can help detect cancer at early stages

01/23/2008 | Examiner (Washington, D.C.), The

Researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine have developed nanoparticles that help preserve biomarkers, which can indicate cancer and other diseases, a step that could lead to cancer detection at much earlier stages. Different biomarkers can be tested by altering the nanoparticles.

View Full Article in:

Examiner (Washington, D.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA